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Abstract  
This work investigates the reverse iontophoretic extraction of lactate, a widely 
used marker of tissue distress in critically ill patients and of sports performance. In 
vitro experiments were performed to establish the relationship between subdermal 
lactate levels and lactate iontophoretic extraction fluxes. Subsequently, the 
iontophoretic extraction of lactate was performed in vivo in healthy volunteers. 
Lactate was quickly and easily extracted by iontophoresis both in vitro and in vivo. 
During a short initial phase, iontophoresis extracts the lactate present in the skin 
reservoir, providing information of relevance, perhaps, for dermatological and 
cosmetic applications. In a second step, lactate is extracted from the interstitial 
subdermal fluid allowing local lactate kinetics to be followed in a completely non-
invasive way. The simultaneous in vivo extraction of chloride, and its possible role as 
an internal standard to calibrate lactate reverse iontophoretic fluxes, was also 
demonstrated. Despite these positive findings, however, considerably more research is 
necessary to eliminate potential artefacts and to facilitate interpretation of the data. 
 
Introduction 
Lactic acid is a product of both anaerobic and aerobic metabolism
1
. 
Hyperlactatemia in critically ill patients occurs via different mechanisms. Under 
hypoxemic conditions, lactate levels increase disproportionately with pyruvate 
concentrations
2-4
; on the other hand, hyperlactatemia, with normal lactate to pyruvate 
ratios (10:1 to 15:1), is observed during the systemic stress response to severe 
infection or injury
2,4
. Generally speaking, lactate is considered an important, although 
unspecific, marker of tissue distress
4,5
, and its levels are routinely measured in critical 
care units because of their prognostic significance, and to evaluate the success of 
therapeutic strategies
2,6-10
. Hyperlactatemia has also been associated with drug 
therapies involving nucleoside analogue reverse transcriptase inhibitors, epinephrine, 
metformin, phenformin
10-13
, and in type I glycogen storage disease
14
. 
As well as these clinical applications, lactate is used as a marker of endurance 
and training efficiency
15-16
. The lactate threshold, the steady-state lactate (MLSS) and 
the maximal lactate steady-state workload (MLSSw) (i.e., workload that can be 
maintained over time without a continual blood lactate accumulation) are used to 
assess sports performance, and are based on serial measurements of systemic lactate 
levels
15-16
. In terms of lactate monitoring, a hand-held device (Accutrend Lactate
®
) 
has recently been introduced for sport and point-of-care applications
8,13
, and active 
research on biosensors, microdialysis and micro-catheterization
17-19
 is in progress. 
These different approaches are invasive, however, monitoring lactate either directly in 
the blood, or in the subcutaneous tissue and deeper organs, and require trained 
personnel. There exists, therefore, a rationale for the development of non-invasive 
technology, which can reduce the risk of infection, allow continuous monitoring, and 
offer a practical alternative for ambulatory care.  
Reverse iontophoresis is a minimally invasive procedure which applies small 
electrical currents to the skin to enhance the transdermal transport of substances 
across the barrier
20
. The potential of this method has been demonstrated by the 
development of the GlucoWatch G2 Biographer
®
 
21
 which can monitor glycemia, in a 
essentially continuous manner, for as long as 12 hours. While this device is not yet 
optimized, it is quite benign apart from the calibration procedure that requires a 
conventional finger-stick. Even this drawback may be addressed by a refinement of 
the technique which uses an internal standard approach that can render the method 
completely non-invasive
22-23
. Indeed, this strategy has been successfully applied to 
predict the blood levels of lithium in bipolar patients being treated with this drug
24
. 
The internal standard procedure takes advantage of the fact that all ions present in the 
interstitial fluid are extracted with an efficiency that depends on their concentration 
and mobility. The internal standard is selected from the electrolytes present and its 
concentration is ideally high and relatively constant; i.e., its iontophoretic flux (JI.S.) is 
effectively constant and can be used to normalize that of the analyte of interest 
(Janalyte) according to Eq.1:  
Janalyte / JI.S. = γ
#
 . Canalyte   Equation 1 
where γ
#
 is the proportionality constant relating the ratio of iontophoretic extraction 
fluxes to the subdermal concentration of the analyte, Canalyte.  
The objective of this work was to investigate the feasibility of non-invasively 
monitoring lactate by reverse iontophoresis. Lactic acid, a small and negatively 
charged compound at physiological pH (MW = 90.1, pKa = 3.9), constitutes an 
excellent candidate for reverse iontophoretic extraction. L-lactate plasma 
concentrations in healthy adults fall in the range of 0.4-1.8 mM, increasing to 2-5 mM 
in severely injured patients, or during sport exercise
2,4,10,25
. 
In vitro experiments were first performed to examine the relationship between 
subdermal lactate levels and iontophoretic extraction fluxes. The specific aim was to 
validate a linear relationship between lactate transport (JLactate) and the subdermal 
concentration of the analyte (CLactate): 
JLactate = γ. CLactate   Equation 2 
In Eq.2, γ is a constant which depends on the efficiency of the iontophoretic 
extraction of lactate. In a second step, the transdermal iontophoretic extraction of 
lactate was carried out in vivo in healthy volunteers. The simultaneous extraction of 
chloride as a possible internal standard for lactate extraction was also investigated. 
 
Materials and Methods 
Materials 
Porcine ears were obtained fresh from an abattoir (Société d’Exploitation 
d’Abbatage, Annecy, France) and cleaned under cold running water. Skin was 
removed with a dermatome set to 750 µm (Zimmer™ Air Dermatome, Dover, Ohio) 
and cut into small squares (9 cm
2
), which were wrapped individually in Parafilm™ 
and maintained at -20°C for no longer than one month before use. 
Sodium chloride, L-lactate acid sodium salt, and HEPES buffer were obtained 
from Fluka (St Quentin Fallavier, France). Glycine-glycine; glycine-glycine 
hydrochloride, L-glutamic acid, glutamic pyruvic transaminase (L-alanine 
aminotransferase, ALAT) from porcine heart, L-lactic dehydrogenase type VIII (L-
LDH) from chicken heart, and β-nicotinamide adenine dinucleotide were obtained 
from Sigma-Aldrich (St Quentin Fallavier, France) and Roche Diagnostics France 
(Meylan, France). De-ionized water (resistivity > 18 Mohm/cm
2
) was used to prepare 
all solutions. 
In vitro iontophoretic experiments. 
The skin was mounted between the upper and lower parts of vertical 
iontophoresis cells
26
; the area available for transport was 0.73 cm
2
. The anodal and 
cathodal compartments were filled with unbuffered 50 mM NaCl. The subdermal 
donor compartment was charged with 25 mM HEPES buffered at pH 7.4, containing 
133 mM NaCl, to which different concentrations of L-lactate (0.5 – 4 mM) were 
added (n = 6). Direct current (0.4 mA) was applied for 5 hours via Ag/AgCl 
electrodes from a power supply (Kepco APH-1000DM, MB Electronique, France). 
The entire contents of the anodal compartment were removed every hour and 
analyzed for L-lactate using an enzymatic assay described below. In a control 
experiment, which investigated iontophoretic extraction of the endogenous L-lactate 
reservoir (n = 3), the subdermal solution contained no lactate whatsoever. A second, 
no-current, control experiment measured the passive flux of L-lactate from a 4 mM 
subdermal donor (n = 12). 
 
 
In vivo experiments 
The clinical protocol was approved by the internal review board of the Geneva 
University Cantonal Hospital. Informed consent was obtained from all participants 
(aged 25-40 years), who were normal and healthy, and who had no history of skin 
disease. Four subjects (A-D) participated on a single occasion, and a single volunteer 
participated twice (E1, E2). The volunteers were allowed to eat and drink during the 
experiments. Two glass chambers (2 cm
2
) were fixed to the forearm (at a site which 
had been cleaned with an alcohol swab) using a Teflon ring and sealed with silicone 
grease. The ensemble was held firmly in place with medical tape (3M 9772L Foam 
Tape, 3M Healthcare, St Paul, MN, USA). The chambers were filled with 1.2 mL of 
unbuffered saline (15 mM); Ag/AgCl electrodes were then introduced and maintained 
at least 5 mm from the skin surface by means of a plastic lid that covered the cell.  
The outward flux of chloride was also measured in these experiments.  This was 
easier to accomplish against a lower ‘background’ level of Cl
-
 in the electrode 
chambers, explaining the use of 15 mM NaCl in vivo (as compared to 50 mM in 
vitro).  A Phoresor II Auto (Model PM850, Iomed Inc., Salt Lake City, UT) delivered 
a constant, direct current of 0.6 mA (0.3 mA/cm
2
) for 5 hours during which 20 
samples were removed at intervals of 15 minutes. At the end of each interval, the 
current was stopped and the electrode solutions were completely removed and 
refreshed. The samples were subsequently analyzed for lactate and chloride by ion-
chromatography (see below). After 1 hour, capillary blood lactatemia was measured 
at the beginning of each sampling cycle using a conventional blood lactate monitor 
(Accutrend Lactate
®
, Roche Diagnostics, Mannheim, Germany).  
Analytical chemistry 
For the in vitro experiments, the enzymatic assay used for L-lactate was based 
on a modification of previously published methods
27-28
, and involved the conversion 
of L-lactate to pyruvate by L-LDH and the associated reduction of NAD
+
 to NADH. 
Pyruvate was consumed by transamination by ALAT to drive the reaction to NADH. 
Briefly, 200 µl of sample was mixed with 700 µl of glycine-glycine buffer (210 mM) 
and 100 µL of an aqueous solution of NAD in water (8 mg/mL). The glycine-glycine 
buffer (pH 10) contained 35 mM L-glutamate and the appropriate concentration of 
enzymes to provide 14 units of ALAT and 84 units L-LDH per sample. The reaction 
was carried out at 25°C for 11 minutes, after which the amount of NADH formed was 
quantified by fluorescence (excitation = 340 nm, emission = 450 nm). A calibration 
curve was generated before each set of measurements. 
For the in vivo samples, lactate and chloride were assayed by ion 
chromatography (Dionex ion chromatograph 600 system, Dionex, Sunnyvale, CA) 
equipped with a gradient pump (GP-50), a thermal compartment (AS-50) and an 
electrochemical detector (ED-50). Separation was accomplished on an anion column 
(AS-11) preceded by a guard column (AG-11) through which a 20 mM sodium 
hydroxide mobile phase was perfused. Quantification was performed in the 
suppressed conductivity mode; the electric current applied to the suppressor (ASRS 4) 
was 50 mA.  
Data analysis and statistics 
Lactate iontophoretic fluxes were directly calculated from the amount (moles) 
extracted in each collection interval normalized by the duration of the interval (hours). 
Chloride transport (QCl,transported) was determined by mass balance:  
QCl,final = QCl,initial - QCl,anode + QCl,transported   Equation 3 
where QCl,final and QCl,initial are the amounts of chloride present at the anodal solution 
at the end and beginning of a sampling interval, respectively. QCl,anode is the amount of 
chloride consumed at the anode during the sampling interval (t), that is:  
QCl,anode = I·t/F      Equation 4 
where I is the current in Amperes (or Coulombs per second), and F is Faraday’s 
constant (96,500 Coulombs).  The transport number of an ion, which is the fraction of 
the total charge transported by this species, was calculated from Eq.5:  
ii
i
JFz
I
t
⋅⋅
=       Equation 5 
where Ji is the iontophoretic extraction flux of the ion (moles/second), and z is the 
valence.  
The efficiency of lactate extraction (γ) in vitro, was obtained by regression of 
the JLactate data with respect to CLactate. In vivo, γ was determined at each sampling 
interval by dividing the lactate flux (JLactate) by the average lactate concentration in the 
blood over the sampling interval (i.e., the mean of the capillary blood concentrations 
measured at the beginning and end of each sampling period): 
( ) 2/finalinitial
Lactate
blood
Lactate
cc
J
c
J
+
==γ    Equation 6 
where Cblood is the averaged lactatemia that corresponds to the iontophoretic interval 
during which a flux JLactate is measured. 
In vivo lactate fluxes are plotted at the mid-point of the sampling interval, 
while blood concentrations are shown at the actual time of measurement. Data are 
expressed as mean ± standard deviation (SD). Statistical tests and linear regression 
analysis were performed with Graph Pad Prism 3.02 software (San Diego, CA). The 
significance of the linear regressions was tested by the corresponding ANOVAs. The 
level of statistical significance was fixed at p ≤ 0.05. 
 
Results and Discussion 
The in vitro experiments demonstrated that L-lactate iontophoretic extraction 
fluxes were easily measurable and increased proportionally with the subdermal 
concentration of the analyte (Figures 1 and 2). The correlation between JLactate and 
CLactate, however, was acceptable only after current had been applied for 2 hours, with 
the coefficient of determination, r
2
 (which indicates the proportion of the total 
variation in the flux that is explained by the fitted regression) being quite low until the 
third interval of extraction (Table 1). The poor linearity observed during the initial 
phase of extraction is probably due to an endogenous reservoir of L-lactate in pig-
skin. To confirm this hypothesis, a control experiment was performed in which no 
lactate was introduced into the subdermal solution. The fact that appreciable lactate 
was nevertheless extracted to the anode (Figure 1) confirmed that lactate must have 
been stored in the skin. In fact, in this control study, the iontophoretic extraction flux 
of lactate during the first hour of current passage was approximately equal to that 
measured when the subdermal solution contained up to 2 mM lactate. Skin reservoirs 
for glucose
29
, urea
30
 and (in bipolar patients taking the drug) lithium
24
 have been 
previously observed. L-lactate accumulates in the skin as a product of glycolysis
31
 
and, at a lower level, from sweating
32-34
. Furthermore, additional lactate accumulation 
in excised pig ear skin may be due to post-mortem glycolysis
35-36
. It follows that these 
in vitro experiments may overestimate the magnitude of the lactate reservoir in vivo. 
Finally, it should be noticed that passive lactate fluxes were 9.6±16.3 and 6.4±12.4 
nmol/h after 2 and 6 hours of transport, respectively: this means that iontophoresis not 
only enhanced significantly the transdermal flux of lactate, but that it also accelerated 
the rate at which the reservoir of compound was cleared from the skin. 
Once endogenous lactate had been emptied from the skin, the iontophoretic 
flux became progressively more dependent on the subdermal concentration, (as shown 
by higher values of r
2 
in Table 1). From the third hour of extraction, the pooled value 
of γ (Eq.2) was 9.3 µl.h
-1
 (23 µl.h
-1
.mA
-1
), which represents the efficiency of the 
lactate extraction process (Figure 2, Table 1). For lithium, γ has been reported to be 
42 µl.h
-1
 (105 µl.h
-1
.mA
-1
)
37
, consistent with a higher efficiency of extraction for this 
smaller cation. In contrast, for phenytoin, a larger and only partially (12%) charged 
anion, γ was only 0.84 µl/h (2.1 µl
.
h
-1
.mA
-1
)
38
. The transport number of lactate was 
calculated to be 0.13% for the 0.5 mM subdermal solution, increasing to 0.34% at 4 
mM. Lactate competes with other anions present in the subdermal compartment, and 
with cations (e.g., Na
+
) being “delivered” from the anode, to transport the charge 
across the skin. Obviously, lactate competes better as its concentration increases, 
allowing a bigger fraction of charge flowing to be carried by the analyte. 
The second phase of this work explored the feasibility of iontophoretically 
extracting lactate in vivo, in humans (Figure 3). It was demonstrated right away that 
lactate was easily extractable and quantifiable even with relatively short sampling 
intervals of only 15 minutes (Figure 3). This confirmed that lactate is a good 
candidate for reverse iontophoretic sampling, and the high efficiency of the process 
suggested that lactate kinetics may be followed non-invasively. It was further 
observed that a significant skin reservoir of lactate was present in all individuals 
studied, and lactate fluxes were high in the first sampling periods. As previously 
mentioned, lactate is known to accumulate in the skin
31-34
; indeed, NMR has been 
used to suggest that lactate represents ~10% of water-extractable materials of human 
stratum corneum
34
, and 25% of its ionic composition. Lactate extraction during the 
first sampling interval was 184 ± 95 nmol/cm
2
, a value in good agreement with that 
obtained by extraction of the analyte from stratum corneum (209 nmol/cm
2
 
33
). It 
follows that the initial, short periods of iontophoresis can provide “local” information 
about lactate and other components of the skin’s natural moisturizing factor
34
 that 
may be useful for dermatological and cosmetic purposes. 
Once the skin reservoir had been depleted, the reverse iontophoretic fluxes of 
lactate could be compared with capillary blood levels. In previous work, good 
agreement between the plasma levels of both lithium and glucose and their respective 
extraction fluxes
23,24,30
 have been observed, indicating a relatively fast equilibrium 
between systemic and subdermal interstitial fluid levels for these two compounds. As 
a result, the efficiency of extraction could be estimated from the blood levels. On the 
contrary, it has been shown that subcutaneous, arterial, venous and capillary 
concentrations of lactate are not always in equilibrium
39-41
, and this is reinforced by 
the results in Figures 3 and 4. In some cases (C and E1) iontophoretic extraction 
followed blood levels, and the apparent efficiencies of extraction (γ) were relatively 
constant throughout the experiment (Figure 4):- subject C: γ = 73 ± 6.3 µl.h
-1
; subject 
E1: γ = 51 ±11 µl.h
-1
. However, in the other volunteers, γ was very high during some 
of the sampling intervals, especially those towards the end of the experiment (Table 
2). It has been reported that subcutaneous adipocytes release lactate both in the post-
absorptive state and under hyper-insulinemia conditions
39-41
. Postprandial 
concentrations of lactate in subcutaneous tissue are significantly higher that the 
corresponding arterial and plasma values
39-41
. Because the subjects were allowed to 
eat and drink during this preliminary in vivo study, the high iontophoretic fluxes (and 
apparent efficiencies of extraction) may be the result of high postprandial 
concentrations of lactate in the subcutaneous interstitial fluid subsequent to the 
ingestion of nourishment.  Thus, while, the data in Figures 3 and 4 support the 
feasibility of lactate monitoring by reverse iontophoresis in vivo, additional work is 
clearly needed to better control for potential artefacts and to facilitate interpretation of 
the results. 
Finally, because reverse iontophoresis is non-specific, it was possible to 
measure, using the same in vivo samples, the extraction of chloride as well; these 
unique results are in Table 2. The deduced Cl
-
 transport number was 44 ± 8%, a value 
in reasonable agreement with that measured previously in vitro and indicative of the 
skin’s cation permselectivity
42
. The constancy of the experimental chloride fluxes 
suggests that this anion may be a useful internal standard with which to normalize the 
iontophoretic extraction of negatively-charged compounds, in the same way that 
sodium has been used for cations
24
. However, the use of Ag/AgCl electrodes imposes 
some limitations; first, a theoretical estimate of the amount of Cl
-
 consumed at the 
anode must be determined and, second, chloride must already be present in the anode 
solution to participate in the electrode reaction. In other words, the chloride 
transported through the skin is extracted into a solution that already contains a certain 
amount of chloride. Needless to say, this imposes an analytical challenge in that the 
change in the Cl
-
 content of the anode solution must be sufficiently large to be reliably 
quantified. Generally speaking, in the experiments reported here, this was the case; 
however, the occasionally observed aberrant values are a signal that the use of Cl
- 
as 
an effective internal standard will require careful optimization.  
 
Conclusions 
This work demonstrates, in vitro and in vivo, that lactate can be quickly and 
easily extracted across the skin by reverse iontophoresis. In a short initial phase, 
iontophoresis extracts the lactate present within a skin depot, providing information of 
potential interest in dermatological and cosmetic applications. Subsequently, lactate is 
transported from the subdermal interstitial fluid allowing lactate kinetics to be 
followed in a completely non-invasive way. Considerably more research is necessary, 
however, to fully exploit the potential benefits of the approach in an ambiguous 
manner. 
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 Figure legends 
 
Figure 1: In vitro iontophoretic extraction fluxes of lactate as a function of sampling 
time and lactate subdermal concentration. In order to facilitate visualization of the 
data, the symbols corresponding to the 0.5 and 1 mM subdermal donors have been 
slightly displaced. 
 
Figure 2: Correlations between lactate iontophoretic fluxes and the subdermal 
concentration of the analyte after 3, 4 and 5 hours of current passage. The regression 
analyses of the data are in Table 1. 
 
Figure 3: Capillary blood lactate profiles and reverse iontophoretically extracted 
lactate in five volunteers. Subject E participated on two occasions (panels E1 and E2). 
 
Figure 4: Evolution of the apparent extraction efficiency of lactate (γ) in vivo as a 
function of time.  
 
Table 1: Linear regressions of the data in Figure 2 according to the equation: JLactate
 
= 
γ • CLactate + Intercept. JLactate is the anodal extraction flux of lactate in 
nanomoles/hour, and CLactate is its subdermal concentration in mM. All the regressions 
were significant (p<0.001). The mean values (±95% confidence of interval) for the 
slope and the intercept are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* 
Pooled values from the results at 3, 4 and 5 hours. 
Time (hr) γ (µL.h
-1
) Intercept (nmol.h
-1
)  r
2
 
1 7.2 ± 3.5 31.4 ± 7.9 0.34 
2 8.9 ± 2.2 18.3 ± 5.1 0.69 
3
*
 9.4  ± 1.7 13.1 ± 3.9 0.78 
4
*
 9.4 ± 1.7 11.6 ± 4.0 0.80 
5
*
 9.0 ± 1.4 10.8 ± 3.2 0.83 
Pooled values
*
 9.3  11.8  
 Table 2: In vivo extraction fluxes of chloride (µmoles/hour) 
 
Subject A B C D E.1 E.2 
Mean 9.55 9.10 8.02 8.92 9.93 12.64 
S.D. 0.70 0.95 1.17 3.39 0.57 1.50 
C.V. (%) 7.3 10.4 14.6 38.1 5.8 11.9 
n
*
 18 16 16 16 15 14 
 
* The total number of sampling intervals (n) was 20. Missing fluxes were aberrant values as 
determined by a Dixon test (p < 0.95). 
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Figure 3 
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Figure 4 
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